"Serial Monitoring of Circulating Tumor Cells Predicts Outcome of Induction Biochemotherapy plus Maintenance Biotherapy for Metastatic Melanoma" by Kazuo Koyanagi

Article

Serial Monitoring of Circulating Tumor Cells Predicts Outcome of Induction Biochemotherapy plus Maintenance Biotherapy for Metastatic Melanoma

Clinical Cancer Research (2010)

Kazuo Koyanagi, John Wayne Cancer Institute
Steven J. O'Day, Angeles Clinic and Research Institute
Peter Boasberg, Angeles Clinic and Research Institute
Michael B. Atkins, Harvard University
He Jing Wang, University of California, Los Angeles
Rene Gonzalez, University of Colorado Denver
Karl Lewis, University of Colorado Denver
John A. Thompson, University of Washington
Clay M. Anderson, University of Missouri
Jose Lutzky, Mount Sinai Hospital
Thomas T. Amatruda, Humphrey Cancer Center
Evan Hersh, University of Arizona
Jon Richards, Oncology Specialist, S.C.
Jeffrey S. Weber, University of Southern California
Dave S B Hoon

Link

Disciplines

Publication Date

April 15, 2010

DOI

10.1158/1078-0432.CCR-10-0037

Citation Information

Kazuo Koyanagi, Steven J. O'Day, Peter Boasberg, Michael B. Atkins, et al.. "Serial Monitoring of Circulating Tumor Cells Predicts Outcome of Induction Biochemotherapy plus Maintenance Biotherapy for Metastatic Melanoma" Clinical Cancer Research Vol. 16 Iss. 8 (2010) p. 2402 - 2408
Available at: http://works.bepress.com/dave-hoon/165/